Medicinova (MNOV) Accounts Payables (2010 - 2025)
Medicinova's (MNOV) quarterly Accounts Payables came in at $624995.0 in Q4 2025, down 43.31% year-on-year from $1.1 million in Q4 2024, and down 16.22% on a QoQ basis from $745958.0 in Q3 2025.
Medicinova (MNOV) Accounts Payables (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Accounts Payables data on file, last reported at $624995.0 in Q4 2025.
- On a quarterly basis, Accounts Payables fell 43.31% year-over-year to $624995.0 in Q4 2025; TTM through Dec 2025 was $624995.0, a 43.31% decrease from a year earlier, with the FY2025 full-year figure at $624995.0, down 43.31% from the prior year.
- Accounts Payables for Q4 2025 stood at $624995.0, down from $745958.0 in the prior quarter.
- Over the last five years, Accounts Payables for MNOV reached as high as $1.1 million in Q4 2024 and fell as low as $402740.0 in Q4 2021.
- Historically, Accounts Payables has averaged $659113.9 across 5 years, with a median of $642526.0 in 2021.
- Across the five-year window, Accounts Payables surged 136.42% in 2023 and slumped 43.31% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $402740.0 in 2021, then increased by 5.44% to $424646.0 in 2022, then jumped by 136.42% to $1.0 million in 2023, then increased by 9.82% to $1.1 million in 2024, then sank by 43.31% to $624995.0 in 2025.
- Per Business Quant data, the three most recent Accounts Payables figures were $624995.0 in Q4 2025, $745958.0 in Q3 2025, and $569445.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 624,995.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 624,995.00 |
| Sep 30, 2025 | 745,958.00 |
| Jun 30, 2025 | 569,445.00 |
| Mar 31, 2025 | 718,891.00 |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 708,203.00 |
| Jun 30, 2024 | 667,695.00 |
| Mar 31, 2024 | 804,764.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 736,896.00 |
| Jun 30, 2023 | 548,221.00 |
| Mar 31, 2023 | 585,065.00 |
| Dec 31, 2022 | 424,646.00 |
| Sep 30, 2022 | 552,720.00 |
| Jun 30, 2022 | 642,634.00 |
| Mar 31, 2022 | 665,249.00 |
| Dec 31, 2021 | 402,740.00 |
| Sep 30, 2021 | 642,418.00 |
| Jun 30, 2021 | 607,155.00 |
| Mar 31, 2021 | 428,152.00 |